Literature DB >> 7614974

Transforming growth factor-beta 1-induced expression of the mucosa-related integrin alpha E on lymphocytes is not associated with mucosa-specific homing.

F Austrup1, S Rebstock, P J Kilshaw, A Hamann.   

Abstract

The integrin alpha E (HML-1, alpha IEL, alpha M290) is largely expressed on lymphocytes in epithelial sites, especially the gut mucosa. We investigated whether alpha E has any role in homing or delineates a phenotype with distinct migratory behavior. Lymph node T cells were stimulated for 5 days with anti-CD3 in the presence or absence of transforming growth factor (TGF)-beta 1 to generate alpha E+ or alpha E- cells, respectively. The two populations were then tested for their homing properties in mice. Both alpha E+ (TGF-beta-treated) and alpha E- (control) cells of either CD4+ or CD8+ subset had a low capacity to enter the gut and showed the same homing behavior with respect to a variety of other organs. The same was true for alpha E+ and alpha E- cells that had been briefly stimulated with anti-CD3 (24 h) and then allowed to return to a resting state before injection, though in this case both populations showed a greater capacity to recirculate through lymphoid tissue than was seen with fully activated cells. The results indicate that alpha E beta 7 does not act as a homing receptor, and that the expression of the site-specific marker alpha E does not correlate with a distinct homing behavior.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614974     DOI: 10.1002/eji.1830250602

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

Review 1.  Alpha E beta 7.

Authors:  P J Kilshaw
Journal:  Mol Pathol       Date:  1999-08

Review 2.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).

Authors:  M J Leckie; G R Jenkins; J Khan; S J Smith; C Walker; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

4.  Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.

Authors:  F L Wormley; J Chaiban; P L Fidel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo.

Authors:  Kerstin Siegmund; Markus Feuerer; Christiane Siewert; Saeed Ghani; Uta Haubold; Anja Dankof; Veit Krenn; Michael P Schön; Alexander Scheffold; John B Lowe; Alf Hamann; Uta Syrbe; Jochen Huehn
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

Review 6.  Layers of mutualism with commensal bacteria protect us from intestinal inflammation.

Authors:  C Mueller; A J Macpherson
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

7.  Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells.

Authors:  Joachim Lehmann; Jochen Huehn; Maurus de la Rosa; Frank Maszyna; Ute Kretschmer; Veit Krenn; Monika Brunner; Alexander Scheffold; Alf Hamann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 8.  Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.

Authors:  Christopher C Denucci; Jason S Mitchell; Yoji Shimizu
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

Review 9.  Geography and plumbing control the T cell response to infection.

Authors:  Kamal M Khanna; Leo Lefrançois
Journal:  Immunol Cell Biol       Date:  2008-04-08       Impact factor: 5.126

Review 10.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.